BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1804865)

  • 1. Factors influencing the efficiency of chelation therapy.
    Kostial K; Kargacin B; Arezina R; Landeka M; Simonović I
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):337-50. PubMed ID: 1804865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut retention of metals in rats.
    Kostial K; Kargacin B; Landeka M
    Biol Trace Elem Res; 1989; 21():213-8. PubMed ID: 2484589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age and time of administration of dithiocarbamate analogues on cadmium retention in rats.
    Kargacin B; Kostial K; Arezina R; Singh PK; Jones MM; Cikrt M
    J Appl Toxicol; 1991 Aug; 11(4):273-7. PubMed ID: 1940001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined early treatment with chelating agents DMSA and CaDTPA in acute oral cadmium exposure.
    Sarić MM; Blanusa M; Juresa D; Sarić M; Varnai VM; Kostial K
    Basic Clin Pharmacol Toxicol; 2004 Mar; 94(3):119-23. PubMed ID: 15049341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbodithioate MeOBDCG for decreasing intracellular cadmium deposits in rats of different ages.
    Arezina R; Kargacin B; Kostial K; Jones MM; Singh PK
    Biol Trace Elem Res; 1993; 37(2-3):151-6. PubMed ID: 7688528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
    Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
    Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age.
    Kostial K; Kargacin B; Blanusa M; Landeka M
    Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of chelating agents with cadmium in mice and rats.
    Eybl V; Sýkora J; Koutenský J; Caisová D; Schwartz A; Mertl F
    Environ Health Perspect; 1984 Mar; 54():267-73. PubMed ID: 6734561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age and diet on renal cadmium retention in rats.
    Kostial K
    Environ Health Perspect; 1984 Mar; 54():51-6. PubMed ID: 6734570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
    Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
    Kalia K; Narula GD; Kannan GM; Flora SJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
    Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
    Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dithiocarbamate analog N-(4-methoxybenzyl)-N-dithiocarboxy-D-glucamine reduces the retention of ingested cadmium in rats.
    Kargacin B; Kostial K; Arezina R; Singh PK; Jones MM; Cikrt M
    J Appl Toxicol; 1991 Oct; 11(5):313-5. PubMed ID: 1783734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc.
    Waters RS; Bryden NA; Patterson KY; Veillon C; Anderson RA
    Biol Trace Elem Res; 2001 Dec; 83(3):207-21. PubMed ID: 11794513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning.
    Jones MM; Weaver AD; Weller WL
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):581-8. PubMed ID: 216066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
    Gong Z; Evans HL
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of repeated parenteral administration of several chelators on the distribution and excretion of cobalt.
    Llobet JM; Domingo JL; Corbella J
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):225-33. PubMed ID: 2839877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.